Canadian organ donation organizations' donor audit processes: an environmental scan

Samara Zavalkoff1,2,3, Shauna O'Donnell4, Isabela F Karam4

  • 1Division of Critical Care, Department of Pediatrics, McGill University, Montreal, QC, Canada. samara.zavalkoff@mcgill.ca.

Abstract

Insights

Canadian organ donation systems lack national standards for deceased donor audits (DAs), leading to missed donation opportunities. Standardizing DAs is crucial for improving organ transplantation and supporting donor families.

Area of Science:

  • Organ Donation and Transplantation
  • Healthcare Systems Analysis
  • Public Health Policy

Background:

  • Deceased donor audits (DAs) are essential for evaluating organ donation and transplantation systems.
  • Missed donation opportunities (MDOs) negatively impact patients, families, and transplant waitlists.
  • Canada currently lacks national standards for DAs, data analysis, and accountability for MDOs.

Purpose of the Study:

  • To conduct an environmental scan of current deceased donor audit (DA) practices across Canadian provincial organ donation organizations (ODOs).
  • To identify variations in DA objectives, frequency, scope, methodology, and reporting.
  • To inform the development of a national strategy for DAs.

Main Methods:

  • An environmental scan involving an electronic survey and semistructured interviews with all eleven provincial ODOs.
  • Data collection focused on DA objectives, frequency, scope, methodology, resources, definitions, metrics, and reporting processes.
  • The scan was conducted in July and October 2019.

Main Results:

  • All eleven ODOs participated, revealing significant variability in DA practices.
  • Primary DA purposes included estimating donor potential (45%) and assessing system performance (provincial 27%, hospital 27%).
  • Frequency, methodology, donor definitions, and metrics varied widely across jurisdictions.

Conclusions:

  • Significant inconsistencies exist in Canadian ODOs' DA methodology, definitions, timeliness, data collection, and reporting.
  • The variability highlights the urgent need for a national DA strategy.
  • A national strategy is essential to minimize preventable harm caused by MDOs to patients and families.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
20
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
379